{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-004441","form_type":"8-K","ticker":"TDOC","cik":"0001477449","company_name":"Teladoc Health, Inc.","filed_at":"2023-01-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.169602+00:00","generated_at":"2026-06-20T13:55:26.660298+00:00","sec_items":["2.05","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Teladoc Health cuts workforce 6% (~300 roles), expects $17M in 2023 restructuring charges","bullets":["Layoffs affect ~300 non-clinician employees, ~6% of workforce; office space reductions in certain markets.","Q4 2022 pre-tax charges of $4.4M ($2M severance, $2.4M exit costs); expects ~$17M in charges in 2023.","Of 2023 charges, ~$10M are cash expenditures for workforce reductions; also expects $6M reduction in stock-based compensation.","CEO cites redundant roles from post-merger integration and need for balanced growth of revenue and profitability."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-004441","json":"https://secwatch.observer/filing/0001104659-23-004441.json","markdown":"https://secwatch.observer/filing/0001104659-23-004441.md","text":"https://secwatch.observer/filing/0001104659-23-004441.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477449/000110465923004441/0001104659-23-004441-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477449/000110465923004441/tm233566d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T13:55:26.660298+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"203dc8f583379cad2250d544fd8b2ac9d668891d","claim":"Teladoc Health, Inc. announced a restructuring with charges of approximately $17 million in pre-tax charges in 2023 affecting the Company (approximately 6 percent).","evidence_excerpt":"On January 18, 2023, Teladoc Health, Inc. (the “Company”) announced a restructuring plan intended to reduce operating costs. In addition, the Company underwent certain other cost-saving actions taken during the latter part of the fourth quarter of 2022. The combination of these actions results in a reduction of the Company’s workforce of approximately 6 percent, and office space reductions within certain markets.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000110465923004441/0001104659-23-004441-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"approximately $17 million in pre-tax charges in 2023"},{"label":"Affected area","value":"the Company"},{"label":"Headcount","value":"approximately 6 percent"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}